MDH Issues Advisory on RSV Monoclonal Antibodies Use

March 26, 2026

Last week, the Minnesota Department of Health (MDH) issued a health advisory that extends the use of RSV Monoclonal Antibodies through April 30. 

Physicians are advised to: 

  • Continue administering RSV monoclonal antibody products (RSV-mAbs) to eligible infants and young children through April 30, 2026. 

  • Use your electronic health record (EHR) or other system to pull lists of clients due for RSV-mAbs, and conduct outreach to those clients to encourage them to receive a dose before the end of the extended respiratory season.  

  • Continue to advise patients and caregivers to take measures to prevent the spread of respiratory illnesses, including staying home when sick, practicing good hand hygiene, covering coughs and sneezes, and keeping infants away from individuals who are ill.  

  • Report RSV-associated hospitalizations according to Minnesota Department of Health (MDH) reporting guidance.   

See the full advisory here. 

Latest News

DFL Expands Majority in Minnesota Senate, Breaks Tie to Regain Control of the House

November 5, 2026

Minnesota Democrats had a strong showing on Election Day, November 3, expanding their majority in the Senate, and breaking the two-year tie in the House to regain control of both chambers. 

Measles Cases in Minnesota Continue to Rise

November 5, 2026

The Minnesota Department of Health (MDH) reported on October 29 that the number of measles cases in Minnesota for 2026 has reached a total of 80 cases — the most the state has seen in a single year since 1990.  

Judge Strikes Down Trump Administration’s Definition of Medical Frailty

November 5, 2026

On October 29, a federal judge ruled that the Centers for Medicare and Medicaid Services (CMS) exceeded its authority when it restricted the definition of medical frailty – for the purpose of Medicaid work requirement exemptions– beyond the language in statute H.R. 1 (i.e., the One Big Beautiful Bill Act).